Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
2.
J Pediatr Hematol Oncol ; 20(6): 570-3, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9856682

RESUMEN

PURPOSE: Tachypnea in children is associated with respiratory disorders and nonrespiratory disorders such as cardiac disease, metabolic acidosis, fever, pain, and anxiety. Pulmonary embolism is seldom considered by pediatricians as a cause of tachypnea. PATIENTS AND METHODS: Three children of various ages with persistent tachypnea are described: a girl after orthopedic surgery for kyphoscoliosis, a boy with nephrotic syndrome, and a neonate with Hirschsprung disease. Other causes of tachypnea were diagnosed and treated before pulmonary embolism was considered. RESULTS: Ventilation-perfusion scanning appeared to be highly probable for pulmonary embolism in these patients. Anticoagulant therapy was started. CONCLUSION: Pulmonary embolism should be kept in mind in children with tachypnea, especially when other risk factors for venous thromboembolism are present, to avoid delay in anticoagulant treatment and a fatal outcome.


Asunto(s)
Embolia Pulmonar/diagnóstico , Trastornos Respiratorios/diagnóstico , Anticoagulantes/uso terapéutico , Niño , Preescolar , Femenino , Humanos , Recién Nacido , Pulmón/diagnóstico por imagen , Masculino , Embolia Pulmonar/tratamiento farmacológico , Cintigrafía , Trastornos Respiratorios/diagnóstico por imagen
3.
Blood ; 81(8): 2044-9, 1993 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-8471765

RESUMEN

Glanzmann's thrombasthenia (GT) is the result of the absence or of an altered and dysfunctional expression on the platelet membrane of the fibrinogen receptor (glycoprotein [GP] IIb/IIIa complex). Various molecular genetic mechanisms have been found to be responsible for this inherited disease. In a patient with a severe type of GT, we have found a splice variant in the GP IIIa gene that leads to premature chain termination. Immunoprecipitation experiments, using monoclonal antibodies specific for GP IIb/IIIa, showed that GP IIb/IIIa was not detectable on the platelet membrane. Amplification of reversely transcribed platelet GP IIIa mRNA by the polymerase chain reaction and subsequent sequence analysis showed a 86-bp deletion, which corresponds to exon i of the GP IIIa gene. This deletion results in a shift of the reading frame leading to eight altered amino acids followed by a premature termination codon. Analysis of the corresponding genomic DNA fragments showed three mutations in the exon i-intron i boundary region of the GP IIIa gene. One of these mutations is a G-->T transition that eliminates the GT splice donor site in the wild type. This base pair change creates a restriction site for the enzyme Mse I. Allele-specific restriction enzyme analysis (ASRA) with Mse I of amplified genomic DNA of the parents and the proposita showed that both parents (who are first cousins) are heterozygous, whereas the proposita is homozygous for the G-->T substitution.


Asunto(s)
Eliminación de Gen , Homocigoto , Glicoproteínas de Membrana Plaquetaria/genética , Empalme del ARN/genética , ARN Mensajero/genética , Trombastenia/genética , Adulto , Secuencia de Aminoácidos , Anticuerpos Monoclonales , Secuencia de Bases , Plaquetas/química , ADN/química , Desoxirribonucleasas de Localización Especificada Tipo II , Exones , Femenino , Humanos , Técnicas de Inmunoadsorción , Datos de Secuencia Molecular , Glicoproteínas de Membrana Plaquetaria/química , Reacción en Cadena de la Polimerasa , ARN Mensajero/sangre , Trombastenia/sangre
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda